Glass House Brands Expands Internationally with First European Hemp Sale

  • Glass House Brands completed its first international sale of smokeable CBD biomass to Europe on July 7, 2026.
  • The product came from Greenhouse 4 at the company’s Camarillo Farm, planted for commercial hemp in Winter 2025.
  • All hemp biomass produced is compliant with California regulations and will remain sellable under proposed federal intoxicating hemp bans.
  • Long-term strategy includes positioning production for a potential Medicare reimbursable CBD program.

Glass House Brands’ first international hemp sale marks a strategic shift beyond its core California market, aligning with broader industry trends toward global cannabis expansion. The move also positions the company to capitalize on potential federal regulatory changes, particularly around Medicare reimbursable CBD products. With a focus on compliance and high-value product lines, Glass House is leveraging its scaled production capabilities to navigate evolving legal channels.

Regulatory Compliance
How proposed federal hemp bans will impact Glass House’s ability to maintain sellable product lines.
Market Expansion
The pace at which Glass House can scale international sales beyond Europe.
Strategic Positioning
Whether Glass House can successfully pivot Greenhouse 4 production for a Medicare reimbursable CBD program.